An article in Ontario’s Mississauga News reports on a nurse winning a $5,000 award from pharmaceutical giant Bayer’s “Bayer Dream Fund“, given “to support the dream of a Canadian who is effectively managing their diabetes”. That nurse’s dream? She is “creating a local exercise program for people with diabetes who also experience mental illness”.

It’s a nice article about the many struggles the increasing number of people dealing with “mental illness” who are also contracting diabetes have. There are just two curious omissions: First, Bayer markets both insulin and glucose meters, so it’d be nice if the article disclosed that all this is simply part of a Bayer marketing initiative. Second, Bayer also markets antipsychotic drugs for people diagnosed with mental illnesses, and it’s this popular class of medications that are causing skyrocketing diabetes!

The research is growing rapidly that antipsychotic drugs interfere with metabolic processes in such a way as to induce diabetes–accounting for why people taking antipsychotic medications are 2-4 times more likely to develop diabetes. Historical studies have shown that being diagnosed with mental illnesses does not predispose people to developing diabetes. While poor modern diets may still be a factor in the process, the evidence is piling in that antipsychotic medications themselves are the main cause, and the fact that such an article would simply not even mention these links aptly exemplifies the typical abject gullibility of Canadian media, and their willingness to be utterly manipulated by pharmaceutical company PR shills.